Slimming direct with Mounjaro: separating the search from the reality

Mounjaro (tirzepatide) is the only dual GIP and GLP-1 receptor agonist licensed for weight management in the UK, a mechanism distinct from older single-pathway treatments.
Treatment starts at the 2.5 mg dose, which exists specifically to help your body adjust before the dose is gradually increased by the prescriber over subsequent weeks.
UK strengths run from 2.5 mg up to 15 mg; six steps in total, each delivered via a pre-filled KwikPen with four weekly doses per pen.
A prescription is legally required: no UK pharmacy, online or high street, can supply Mounjaro without a prescriber's sign-off following clinical assessment of your individual circumstances.

Searching for slimming, direct, and Mounjaro in the same breath is understandable — tirzepatide has produced some of the most significant weight-loss results in clinical trial history, and people want it quickly. The reality is more layered than a direct-to-door purchase: Mounjaro is a prescription-only medicine in the UK, meaning a qualified prescriber must assess your medical history before any supply can be made. That clinical step is not a barrier placed in your way; it is the thing that keeps the treatment safe and effective for you specifically. Once you understand what genuine, regulated access actually looks like, the process is surprisingly straightforward. Tirzepatide, the active ingredient in Mounjaro, is a dual GIP and GLP-1 receptor agonist — it works by activating two gut-hormone pathways that regulate appetite and blood-sugar levels, slowing gastric emptying and increasing the sense of fullness. In the SURMOUNT-1 trial, participants at the highest dose saw an average body-weight reduction of around 20–21% over 72 weeks, a result that caught the attention of regulators and clinicians worldwide. Mounjaro holds a UK licence for weight management in adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related health condition, and every prescription must be issued by a registered prescriber following individual assessment.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What regulated Mounjaro access looks like in practice, and where the myths creep in

The biggest misconception about buying Mounjaro online

The phrase that trips most people up is the idea that ordering Mounjaro is like ordering any other product online, put it in your basket, pay, receive the parcel. Some sellers actively encourage this impression. They are not operating legally, and the risk attached to what they supply is real.

The MHRA has repeatedly warned the public about counterfeit weight-loss pens sold through social media and unverified websites. In one raid alone, a site in Northampton producing fake tirzepatide pens was shut down in October 2025. Earlier enforcement had already resulted in roughly 20 million doses of illegally traded weight-loss medicines being seized, worth an estimated £45 million. Fake pens have in some cases contained insulin, with serious consequences for people who used them. The MHRA's Yellow Card scheme accepts reports of both suspected side effects and suspect sellers, and using it protects other patients too.

A legitimate online pharmacy will always require a medical consultation before issuing a prescription. You can verify any online pharmacy on the GPhC register in under a minute, it is the single clearest check available to you. Red flags to watch for include sellers offering these medicines without a prescription, prices far below market rates, and social-media storefronts with no verifiable pharmacy registration. The search for a quick, direct route is entirely reasonable. The answer is that a properly run online service genuinely can be fast, but the clinical review cannot be removed.

What the tirzepatide evidence actually says about slimming

It is worth being precise about the results, because the numbers that circulate online are not always applied accurately. The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed adults with obesity over 72 weeks. At the 15 mg maintenance dose, the average reduction in body weight was around 20–21%. That figure comes from thousands of trial participants who also followed a reduced-calorie diet and increased physical activity alongside the injections, the treatment works in combination with lifestyle changes, not independently of them.

A separate head-to-head trial, SURMOUNT-5, published in 2025, compared tirzepatide directly with semaglutide 2.4 mg. Tirzepatide produced a greater average weight reduction over 72 weeks. NICE reviewed this evidence in its appraisal of tirzepatide (TA1026) and acknowledged that indirect comparisons favour tirzepatide, while noting that individual responses vary. No trial result is a personal guarantee, a prescriber assesses whether the evidence applies to your specific situation. For a broader look at how tirzepatide performs as a weight-loss medicine, the clinical picture becomes clearer in context.

The licensed schedule starts at 2.5 mg, a dose whose primary job is letting your digestive system adapt before meaningful dose increases begin. The therapeutic work happens at higher doses, titrated by your prescriber every four weeks or so based on how you're responding and tolerating the medicine.

Side effects to know before you start, not to frighten, but to prepare

The side-effect profile of Mounjaro is led by the gut. Nausea, loose stools, constipation, indigestion and burping are the most commonly reported, particularly in the early weeks of treatment or after a dose increase. For most people these settle within a few days to two weeks. Fatigue and headache are also reported, especially initially.

More serious effects are uncommon but should not be ignored. In January 2026 the MHRA issued a formal Drug Safety Update highlighting acute pancreatitis as a known, infrequent but potentially serious side effect of GLP-1 medicines. If you develop severe stomach pain that persists and travels toward the back (with or without vomiting) stop the injection and seek urgent medical assessment. Gallbladder symptoms, signs of dehydration after severe illness, and allergic reactions are also reasons to contact a clinician promptly.

Mounjaro is not recommended during pregnancy, when trying to conceive, or while breastfeeding. It is not licensed for anyone under eighteen. Women using the combined oral contraceptive pill should add a barrier method for the first four weeks of treatment and for four weeks after each dose increase, because the slowed gastric emptying tirzepatide causes can reduce pill absorption. Full guidance on how Mounjaro is used, including storage, injection technique and what to do if you miss a dose, lives in your Patient Information Leaflet and should always be discussed with your prescriber. If you are still weighing up whether this treatment is right for you, our overview of the Mounjaro slimming jab covers the key questions people have before they begin. The NHS tirzepatide page is also a clear and reliable starting point for side-effect information.

How a regulated service gets Mounjaro to you efficiently

The picture that emerges from the evidence (strong clinical results, real safety considerations, and a mandatory prescription) points toward a specific kind of service: one fast enough to be practical, and careful enough to be safe.

At nume, a GPhC-registered Independent Prescriber reviews your consultation personally, the same day you submit it. There is no algorithm reading your answers. If your application is clinically approved, your order is dispatched the same day provided it arrives before 12pm on a working day. It travels with DPD, tracked, in plain packaging with nothing on the outside to identify what is inside, your pen arrives the next working day, and the DPD notification lands on your phone before the driver does.

Everything is included in one price: the consultation, the prescription, the treatment itself and next-working-day delivery. No subscription, no auto-renewal. Every repeat order goes through the same clinical review before dispatch. You can verify the nume pharmacy registration on the GPhC register at registration number 9012878. For a sense of what treatment costs and what that price covers, the Mounjaro pricing page sets it out plainly. If you have questions before deciding, our FAQ page covers the questions our prescribers hear most often. When you are ready to take the next step, start your free consultation and a prescriber will review your suitability the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions